Compounding and Patient Counseling Flashcards
7 cards from real MPJE practice questions. Tap to flip, then mark Knew It or Still Learning — missed cards come back until you master them.
Read the first 7 Compounding and Patient Counseling flashcards as text
A pharmacist compounds a topical preparation using ingredients obtained from a DEA-registered source but fails to keep a log. Which regulation is primarily violated?
Answer: DEA record-keeping requirements for controlled substance precursors
DEA regulations require pharmacies to maintain accurate records of controlled substances and their precursors; failure is a DEA record-keeping violation.
Which scenario best illustrates appropriate 'anticipatory compounding' permitted under 503A?
Answer: Preparing a small quantity of a compound historically prescribed by local providers based on documented past prescriptions
503A permits limited anticipatory compounding based on a history of receiving valid prescriptions for a preparation in the ordinary course of practice.
A patient counseling session should include information about what to do if a dose is missed. Under MPJE standards, this counseling element falls under:
Answer: Instructions for use of the medication
Instructions for use, including missed-dose procedures, are a core counseling element under OBRA '90 and state pharmacy practice standards.
USP requires that a Media Fill Test for high-risk CSP qualification be performed:
Answer: Every 6 months
Personnel preparing high-risk (Category 2) CSPs must pass a media fill test at least every 6 months to maintain sterile technique qualification.
Which statement about compounding for office use under 503A is accurate?
Answer: 503A pharmacies may furnish reasonable quantities of compounded preparations to practitioners for office administration if permitted by state law
503A permits limited office-use supply to practitioners in reasonable quantities when authorized by the state board of pharmacy.
When a pharmacist detects during counseling that a patient is taking a newly prescribed drug that interacts with a current medication, the pharmacist's primary obligation is to:
Answer: Notify the prescriber and counsel the patient about the interaction before dispensing
The pharmacist's professional duty is to identify the interaction, notify the prescriber, and counsel the patient prior to or instead of dispensing.
A 503B outsourcing facility must register with:
Answer: Both the FDA and the state Board of Pharmacy
503B facilities must register with the FDA and are also subject to state pharmacy board licensing and oversight.